| HIV Infections

Stribild vs Prezista

Side-by-side clinical, coverage, and cost comparison for hiv infections.
Deep comparison between: Stribild vs Prezista with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsPrezista has a higher rate of injection site reactions vs Stribild based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Prezista but not Stribild, including UnitedHealthcare
Sign up to reveal the full AI analysis
Stribild
Prezista
At A Glance
Oral
Once daily
Integrase inhibitor + CYP3A inhibitor + nucleoside/nucleotide analog reverse transcriptase inhibitors
Oral
Once daily or Twice daily
HIV-1 protease inhibitor
Indications
  • HIV Infections
  • HIV Infections
Dosing
HIV Infections One tablet (elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg) taken orally once daily with food in adults and pediatric patients 12 years of age and older with body weight at least 35 kg and creatinine clearance >=70 mL/min.
HIV-1 Infections (treatment-naive adults) Darunavir 800 mg with ritonavir 100 mg once daily, oral, with food
HIV-1 Infections (treatment-experienced adults, no darunavir resistance) Darunavir 800 mg with ritonavir 100 mg once daily, oral, with food
HIV-1 Infections (treatment-experienced adults, at least one darunavir resistance substitution) Darunavir 600 mg with ritonavir 100 mg twice daily, oral, with food
HIV-1 Infections (pregnant patients) Darunavir 600 mg with ritonavir 100 mg twice daily, oral, with food
HIV-1 Infections (pediatric patients, 3 to less than 18 years) Weight-based dosing with ritonavir, oral, with food. Dosage based on body weight and resistance status, not to exceed adult dose
Contraindications
  • Coadministration with alfuzosin
  • Coadministration with carbamazepine, phenobarbital, or phenytoin
  • Coadministration with rifampin
  • Coadministration with lurasidone or pimozide
  • Coadministration with dihydroergotamine, ergotamine, or methylergonovine
  • Coadministration with St. John's wort (Hypericum perforatum)
  • Coadministration with lomitapide, lovastatin, or simvastatin
  • Coadministration with sildenafil when used for pulmonary arterial hypertension
  • Coadministration with triazolam or orally administered midazolam
  • Co-administration with alfuzosin
  • Co-administration with colchicine in patients with renal and/or hepatic impairment
  • Co-administration with rifampin
  • Co-administration with lurasidone
  • Co-administration with pimozide
  • Co-administration with dronedarone
  • Co-administration with ivabradine
  • Co-administration with ranolazine
  • Co-administration with ergot derivatives (dihydroergotamine, ergotamine, methylergonovine)
  • Co-administration with St. John's wort (Hypericum perforatum)
  • Co-administration with elbasvir/grazoprevir
  • Co-administration with lomitapide
  • Co-administration with lovastatin
  • Co-administration with simvastatin
  • Co-administration with naloxegol
  • Co-administration with sildenafil for pulmonary arterial hypertension
  • Co-administration with orally administered midazolam
  • Co-administration with triazolam
Adverse Reactions
Most common (>=5%) Diarrhea, nausea, headache, fatigue
Serious Severe acute exacerbations of hepatitis B in coinfected patients, new onset or worsening renal impairment, lactic acidosis/severe hepatomegaly with steatosis, bone loss and mineralization defects, immune reconstitution syndrome
Postmarketing Allergic reactions including angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia
Most common (>=5%, treatment-naive) Diarrhea, headache, abdominal pain, rash, nausea, vomiting
Most common (>=5%, treatment-experienced) Diarrhea, nausea, rash, abdominal pain, vomiting
Serious Hepatotoxicity, severe skin reactions (Stevens-Johnson Syndrome, toxic epidermal necrolysis), acute pancreatitis, diabetes mellitus, hyperglycemia, immune reconstitution syndrome
Postmarketing Rhabdomyolysis, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, crystal nephropathy, crystalluria
Pharmacology
STRIBILD is a fixed-dose combination of elvitegravir (an integrase strand transfer inhibitor), cobicistat (a CYP3A inhibitor that boosts elvitegravir levels), emtricitabine (a nucleoside reverse transcriptase inhibitor), and tenofovir disoproxil fumarate (a nucleotide reverse transcriptase inhibitor).
Darunavir is an HIV-1 protease inhibitor that selectively inhibits cleavage of HIV-1 Gag-Pol polyproteins in infected cells, preventing formation of mature virus particles.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Stribild
  • Covered on 5 commercial plans
  • PA (0/12) · Step Therapy (0/12) · Qty limit (11/12)
View full coverage details ›
Prezista
  • Covered on 5 commercial plans
  • PA (9/12) · Step Therapy (0/12) · Qty limit (9/12)
View full coverage details ›
UnitedHealthcare
Stribild
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (3/8) · Qty limit (5/8)
View full coverage details ›
Prezista
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (1/8)
View full coverage details ›
Humana
Stribild
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (3/3)
View full coverage details ›
Prezista
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (2/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
$0
Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP)
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Cost estimate not availableGood Days: HIV, AIDS Treatment & Prevention
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
StribildView full Stribild profile
PrezistaView full Prezista profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.